US2386796A
(en)
|
1942-08-05 |
1945-10-16 |
Bond Crown & Cork Co |
Extruding device
|
US4060082A
(en)
|
1976-08-16 |
1977-11-29 |
Mpl, Inc. |
Dual-ingredient medication dispenser
|
DE2855719A1
(de)
|
1978-12-22 |
1980-07-10 |
Siemens Ag |
Zahnaerztliche handstueckanordnung
|
US4336336A
(en)
|
1979-01-12 |
1982-06-22 |
President And Fellows Of Harvard College |
Fused gene and method of making and using same
|
AU545912B2
(en)
|
1980-03-10 |
1985-08-08 |
Cetus Corporation |
Cloned heterologous jive products in bacillies
|
ZA811368B
(en)
|
1980-03-24 |
1982-04-28 |
Genentech Inc |
Bacterial polypedtide expression employing tryptophan promoter-operator
|
NZ199722A
(en)
|
1981-02-25 |
1985-12-13 |
Genentech Inc |
Dna transfer vector for expression of exogenous polypeptide in yeast;transformed yeast strain
|
JPS57181099A
(en)
|
1981-04-29 |
1982-11-08 |
Biogen Nv |
Bacillus cloning vector, recombinant dna molecule, bacillus host transformed thereby and manufacture of polypeptide expressing dna order and being coded thereby
|
US4551433A
(en)
|
1981-05-18 |
1985-11-05 |
Genentech, Inc. |
Microbial hybrid promoters
|
US4405712A
(en)
|
1981-07-01 |
1983-09-20 |
The United States Of America As Represented By The Department Of Health And Human Services |
LTR-Vectors
|
US4769330A
(en)
|
1981-12-24 |
1988-09-06 |
Health Research, Incorporated |
Modified vaccinia virus and methods for making and using the same
|
US4603112A
(en)
|
1981-12-24 |
1986-07-29 |
Health Research, Incorporated |
Modified vaccinia virus
|
US4454121A
(en)
*
|
1982-07-27 |
1984-06-12 |
The University Of Tennessee Research Corporation |
Synthetic peptides corresponding to antigenic determinants of the M protein of Streptococcus pyogenes
|
SE8205892D0
(sv)
|
1982-10-18 |
1982-10-18 |
Bror Morein |
Immunogent membranproteinkomplex, sett for framstellning och anvendning derav som immunstimulerande medel och sasom vaccin
|
US4876197A
(en)
|
1983-02-22 |
1989-10-24 |
Chiron Corporation |
Eukaryotic regulatable transcription
|
CA1341116C
(en)
|
1983-02-22 |
2000-10-17 |
Rae Lyn Burke |
Yeast expression systems with vectors having gapdh or pyk promoters and synthesis or foreign protein
|
JPS59166086A
(ja)
|
1983-03-09 |
1984-09-19 |
Teruhiko Beppu |
新規な発現型プラスミドとそれらを用いて仔牛プロキモシン遺伝子を大腸菌内で発現させる方法
|
US4546083A
(en)
|
1983-04-22 |
1985-10-08 |
Stolle Research & Development Corporation |
Method and device for cell culture growth
|
US4588684A
(en)
|
1983-04-26 |
1986-05-13 |
Chiron Corporation |
a-Factor and its processing signals
|
JPS59205983A
(ja)
|
1983-04-28 |
1984-11-21 |
ジエネツクス・コ−ポレイシヨン |
異種遺伝子を原核微生物で発現させる方法
|
US4663280A
(en)
|
1983-05-19 |
1987-05-05 |
Public Health Research Institute Of The City Of New York |
Expression and secretion vectors and method of constructing vectors
|
IE58011B1
(en)
|
1983-05-27 |
1993-06-16 |
Texas A & M Univ Sys |
Method for producing a recombinant baculovirus expression vector
|
US4689406A
(en)
|
1983-08-10 |
1987-08-25 |
Amgen |
Enhancement of microbial expression of polypeptides
|
US4870008A
(en)
|
1983-08-12 |
1989-09-26 |
Chiron Corporation |
Secretory expression in eukaryotes
|
EP0136907A3
(en)
|
1983-10-03 |
1986-12-30 |
Genentech, Inc. |
A xenogeneic expression control system, a method of using it, expression vectors containing it, cells transformed thereby and heterologous proteins produced therefrom
|
IL73534A
(en)
|
1983-11-18 |
1990-12-23 |
Riker Laboratories Inc |
1h-imidazo(4,5-c)quinoline-4-amines,their preparation and pharmaceutical compositions containing certain such compounds
|
DK518384A
(da)
|
1984-01-31 |
1985-07-01 |
Idaho Res Found |
Vektor til fremstilling af et gen-produkt i insektceller, fremgangsmaade til dens fremstilling samt dens anvendelse
|
US5916588A
(en)
|
1984-04-12 |
1999-06-29 |
The Liposome Company, Inc. |
Peptide-containing liposomes, immunogenic liposomes and methods of preparation and use
|
US6090406A
(en)
|
1984-04-12 |
2000-07-18 |
The Liposome Company, Inc. |
Potentiation of immune responses with liposomal adjuvants
|
US4880734A
(en)
|
1984-05-11 |
1989-11-14 |
Chiron Corporation |
Eukaryotic regulatable transcription
|
EP0164556B1
(en)
|
1984-05-11 |
1994-03-02 |
Chiron Corporation |
Enhanced yeast transcription employing hybrid promoter region constructs
|
US5288641A
(en)
|
1984-06-04 |
1994-02-22 |
Arch Development Corporation |
Herpes Simplex virus as a vector
|
CA1282721C
(en)
|
1984-06-04 |
1991-04-09 |
Bernard Roizman |
Herpes simplex virus as a vector
|
US4738921A
(en)
|
1984-09-27 |
1988-04-19 |
Eli Lilly And Company |
Derivative of the tryptophan operon for expression of fused gene products
|
US4745056A
(en)
|
1984-10-23 |
1988-05-17 |
Biotechnica International, Inc. |
Streptomyces secretion vector
|
US4837148A
(en)
|
1984-10-30 |
1989-06-06 |
Phillips Petroleum Company |
Autonomous replication sequences for yeast strains of the genus pichia
|
US4762915A
(en)
|
1985-01-18 |
1988-08-09 |
Liposome Technology, Inc. |
Protein-liposome conjugates
|
US4797368A
(en)
|
1985-03-15 |
1989-01-10 |
The United States Of America As Represented By The Department Of Health And Human Services |
Adeno-associated virus as eukaryotic expression vector
|
EP0196056B1
(en)
|
1985-03-28 |
1991-05-22 |
Chiron Corporation |
Improved expression using fused genes providing for protein product
|
US6103243A
(en)
*
|
1985-05-15 |
2000-08-15 |
Biotechnology Australia Pty, Ltd |
Oral vaccines
|
US4865974A
(en)
|
1985-09-20 |
1989-09-12 |
Cetus Corporation |
Bacterial methionine N-terminal peptidase
|
US4777127A
(en)
|
1985-09-30 |
1988-10-11 |
Labsystems Oy |
Human retrovirus-related products and methods of diagnosing and treating conditions associated with said retrovirus
|
US4680338A
(en)
|
1985-10-17 |
1987-07-14 |
Immunomedics, Inc. |
Bifunctional linker
|
JPS6296086A
(ja)
|
1985-10-21 |
1987-05-02 |
Agency Of Ind Science & Technol |
複合プラスミド
|
US5139941A
(en)
|
1985-10-31 |
1992-08-18 |
University Of Florida Research Foundation, Inc. |
AAV transduction vectors
|
US5011828A
(en)
|
1985-11-15 |
1991-04-30 |
Michael Goodman |
Immunostimulating guanine derivatives, compositions and methods
|
US5091309A
(en)
|
1986-01-16 |
1992-02-25 |
Washington University |
Sindbis virus vectors
|
US4861719A
(en)
|
1986-04-25 |
1989-08-29 |
Fred Hutchinson Cancer Research Center |
DNA constructs for retrovirus packaging cell lines
|
ES2061482T3
(es)
|
1986-05-02 |
1994-12-16 |
Gist Brocades Nv |
Metodo para la identificacion de secuencias de señal secretora para sintesis de proteina extracelular en bacillus.
|
EP0324789B1
(en)
|
1986-10-02 |
2003-08-20 |
Massachusetts Institute Of Technology |
Methods of regulating metabolic stability of proteins
|
JPS63123383A
(ja)
|
1986-11-11 |
1988-05-27 |
Mitsubishi Kasei Corp |
ハイブリツドプロモ−タ−、発現調節dna配列および発現ベクタ−
|
GB8702816D0
(en)
|
1987-02-07 |
1987-03-11 |
Al Sumidaie A M K |
Obtaining retrovirus-containing fraction
|
US5219740A
(en)
|
1987-02-13 |
1993-06-15 |
Fred Hutchinson Cancer Research Center |
Retroviral gene transfer into diploid fibroblasts for gene therapy
|
JP2795850B2
(ja)
|
1987-03-23 |
1998-09-10 |
ザイモジェネティクス,インコーポレイティド |
酵母発現ベクター
|
US4980289A
(en)
|
1987-04-27 |
1990-12-25 |
Wisconsin Alumni Research Foundation |
Promoter deficient retroviral vector
|
US5057540A
(en)
|
1987-05-29 |
1991-10-15 |
Cambridge Biotech Corporation |
Saponin adjuvant
|
WO1989001973A2
(en)
|
1987-09-02 |
1989-03-09 |
Applied Biotechnology, Inc. |
Recombinant pox virus for immunization against tumor-associated antigens
|
ATE117375T1
(de)
|
1987-09-11 |
1995-02-15 |
Whitehead Biomedical Inst |
Transduktionsveränderte fibroblasten und ihre anwendung.
|
US4929555A
(en)
|
1987-10-19 |
1990-05-29 |
Phillips Petroleum Company |
Pichia transformation
|
WO1989004669A1
(en)
|
1987-11-18 |
1989-06-01 |
Chiron Corporation |
Nanbv diagnostics and vaccines
|
WO1989005349A1
(en)
|
1987-12-09 |
1989-06-15 |
The Australian National University |
Method of combating viral infections
|
CA1340772C
(en)
|
1987-12-30 |
1999-09-28 |
Patricia Tekamp-Olson |
Expression and secretion of heterologous protiens in yeast employing truncated alpha-factor leader sequences
|
US4973551A
(en)
|
1988-01-15 |
1990-11-27 |
Merck & Co., Inc. |
Vector for the expression of fusion proteins and protein immunogens
|
US5098827A
(en)
*
|
1988-02-26 |
1992-03-24 |
The University Of Florida |
Novel bacterial markers for pathogenic group B streptococci
|
JPH03504079A
(ja)
|
1988-03-21 |
1991-09-12 |
カイロン コーポレイション |
組換えレトロウィルス
|
US5662896A
(en)
|
1988-03-21 |
1997-09-02 |
Chiron Viagene, Inc. |
Compositions and methods for cancer immunotherapy
|
US5591624A
(en)
|
1988-03-21 |
1997-01-07 |
Chiron Viagene, Inc. |
Retroviral packaging cell lines
|
US5206152A
(en)
|
1988-04-08 |
1993-04-27 |
Arch Development Corporation |
Cloning and expression of early growth regulatory protein genes
|
US5422120A
(en)
|
1988-05-30 |
1995-06-06 |
Depotech Corporation |
Heterovesicular liposomes
|
AP129A
(en)
|
1988-06-03 |
1991-04-17 |
Smithkline Biologicals S A |
Expression of retrovirus gag protein eukaryotic cells
|
US4912094B1
(en)
|
1988-06-29 |
1994-02-15 |
Ribi Immunochem Research Inc. |
Modified lipopolysaccharides and process of preparation
|
AU627226B2
(en)
|
1988-08-25 |
1992-08-20 |
Liposome Company, Inc., The |
Influenza vaccine and novel adjuvants
|
EP0432216A1
(en)
|
1988-09-01 |
1991-06-19 |
Whitehead Institute For Biomedical Research |
Recombinant retroviruses with amphotropic and ecotropic host ranges
|
US5354846A
(en)
*
|
1988-11-18 |
1994-10-11 |
Michael Kehoe |
Streptolysin O antigen derivatives, its production and uses
|
DE3841091A1
(de)
|
1988-12-07 |
1990-06-13 |
Behringwerke Ag |
Synthetische antigene, verfahren zu ihrer herstellung und ihre verwendung
|
US5238944A
(en)
|
1988-12-15 |
1993-08-24 |
Riker Laboratories, Inc. |
Topical formulations and transdermal delivery systems containing 1-isobutyl-1H-imidazo[4,5-c]quinolin-4-amine
|
GB2233977B
(en)
*
|
1989-01-04 |
1993-03-31 |
Michael Kehoe |
Cytolytic streptolysin o mutants and uses
|
US5217879A
(en)
|
1989-01-12 |
1993-06-08 |
Washington University |
Infectious Sindbis virus vectors
|
ES2055785T3
(es)
|
1989-01-17 |
1994-09-01 |
Eniricerche Spa |
Peptidos sinteticos y su uso como vehiculos universales para la preparacion de conjugados inmunogenos aptos para el desarrollo de vacunas sinteticas.
|
JP2752788B2
(ja)
|
1989-01-23 |
1998-05-18 |
カイロン コーポレイション |
感染および過剰増殖障害の為の組換え療法
|
EP0448650A4
(en)
|
1989-02-01 |
1992-05-13 |
The General Hospital Corporation |
Herpes simplex virus type i expression vector
|
JP3140757B2
(ja)
|
1989-02-06 |
2001-03-05 |
デイナ・フアーバー・キヤンサー・インステイテユート |
パッケージング欠陥hivプロウイルス、細胞系及びその使用
|
EP0388186A1
(en)
|
1989-03-17 |
1990-09-19 |
E.I. Du Pont De Nemours And Company |
External regulation of gene expression
|
DK0465529T3
(da)
|
1989-03-21 |
1998-10-05 |
Vical Inc |
Ekspression af exogene polynukleotidsekvenser i et hvirveldyr
|
US5703055A
(en)
|
1989-03-21 |
1997-12-30 |
Wisconsin Alumni Research Foundation |
Generation of antibodies through lipid mediated DNA delivery
|
US4929624A
(en)
|
1989-03-23 |
1990-05-29 |
Minnesota Mining And Manufacturing Company |
Olefinic 1H-imidazo(4,5-c)quinolin-4-amines
|
HU212924B
(en)
|
1989-05-25 |
1996-12-30 |
Chiron Corp |
Adjuvant formulation comprising a submicron oil droplet emulsion
|
SE8902315D0
(sv)
*
|
1989-06-27 |
1989-06-27 |
Pharmacia Ab |
Anjonbytare
|
JPH04506662A
(ja)
|
1989-07-14 |
1992-11-19 |
アメリカン・サイアナミド・カンパニー |
接合体ワクチンのためのサイトカイニンおよびホルモンのキヤリヤー
|
JP4041535B2
(ja)
|
1989-08-18 |
2008-01-30 |
オックスフォード バイオメディカ(ユーケー)リミテッド |
標的細胞にベクター構造体を運搬する組換レトロウィルス
|
US5585362A
(en)
|
1989-08-22 |
1996-12-17 |
The Regents Of The University Of Michigan |
Adenovirus vectors for gene therapy
|
US5166057A
(en)
|
1989-08-28 |
1992-11-24 |
The Mount Sinai School Of Medicine Of The City University Of New York |
Recombinant negative strand rna virus expression-systems
|
GB8919607D0
(en)
|
1989-08-30 |
1989-10-11 |
Wellcome Found |
Novel entities for cancer therapy
|
US4988815A
(en)
|
1989-10-26 |
1991-01-29 |
Riker Laboratories, Inc. |
3-Amino or 3-nitro quinoline compounds which are intermediates in preparing 1H-imidazo[4,5-c]quinolines
|
IT1237764B
(it)
|
1989-11-10 |
1993-06-17 |
Eniricerche Spa |
Peptidi sintetici utili come carriers universali per la preparazione di coniugati immunogenici e loro impiego per lo sviluppo di vaccini sintetici.
|
AU7007491A
(en)
|
1990-02-02 |
1991-08-08 |
Schweiz. Serum- & Impfinstitut Bern |
Cdna corresponding to the genome of negative-strand rna viruses, and process for the production of infectious negative-strand rna viruses
|
NZ237464A
(en)
|
1990-03-21 |
1995-02-24 |
Depotech Corp |
Liposomes with at least two separate chambers encapsulating two separate biologically active substances
|
US5658731A
(en)
|
1990-04-09 |
1997-08-19 |
Europaisches Laboratorium Fur Molekularbiologie |
2'-O-alkylnucleotides as well as polymers which contain such nucleotides
|
CA2039921A1
(en)
|
1990-04-16 |
1991-10-17 |
Xandra O. Breakefield |
Transfer and expression of gene sequences into central nervous system cells using herpes simplex virus mutants with deletions in genes for viral replication
|
US5821088A
(en)
*
|
1990-05-11 |
1998-10-13 |
Siga Pharmaceuticals, Inc. |
Use of gram-positive bacteria to express recombinant proteins
|
US6737521B1
(en)
*
|
1990-05-11 |
2004-05-18 |
The Rockefeller University |
Delivery and expression of a hybrid surface protein on the surface of gram positive bacteria
|
AU7906691A
(en)
|
1990-05-23 |
1991-12-10 |
United States of America, as represented by the Secretary, U.S. Department of Commerce, The |
Adeno-associated virus (aav)-based eucaryotic vectors
|
US5149655A
(en)
|
1990-06-21 |
1992-09-22 |
Agracetus, Inc. |
Apparatus for genetic transformation
|
IL98715A0
(en)
|
1990-08-13 |
1992-07-15 |
American Cyanamid Co |
Filamentous hemaglutinin of bodetella pertussis as a carrier molecule for conjugate vaccines
|
EP0854193A1
(en)
|
1990-09-21 |
1998-07-22 |
Chiron Corporation |
Human retroviral packaging cell line
|
US5153312A
(en)
|
1990-09-28 |
1992-10-06 |
American Cyanamid Company |
Oligosaccharide conjugate vaccines
|
WO1992007945A1
(en)
|
1990-10-30 |
1992-05-14 |
Dana Farber Cancer Institute |
Cell type specific alteration of levels of gene products in neural cells
|
US5173414A
(en)
|
1990-10-30 |
1992-12-22 |
Applied Immune Sciences, Inc. |
Production of recombinant adeno-associated virus vectors
|
SE9003978D0
(sv)
|
1990-12-13 |
1990-12-13 |
Henrik Garoff |
Dna expressionssystem baserade paa ett virus replikon
|
DE69132031T2
(de)
|
1990-12-20 |
2000-07-13 |
Arch Development Corp., The University Of Chicago |
Kontrolle der genexpression durch ionisierende strahlung
|
DK0872478T3
(da)
|
1991-03-01 |
2003-03-31 |
Minnesota Mining & Mfg |
Mellemprodukter til fremstilling af 1-substituerede, 2-substituerede 1H-imidazo[4,5-c]quinolin-4-aminer
|
US5389640A
(en)
|
1991-03-01 |
1995-02-14 |
Minnesota Mining And Manufacturing Company |
1-substituted, 2-substituted 1H-imidazo[4,5-c]quinolin-4-amines
|
JPH0614756Y2
(ja)
|
1991-06-26 |
1994-04-20 |
株式会社アルテ |
組み立て式の2室式容器兼用注射器
|
DE69233013T2
(de)
|
1991-08-20 |
2004-03-04 |
The Government Of The United States Of America As Represented By The Secretary Of National Institute Of Health, Office Of Technology Transfer |
Adenovirus vermittelter gentransfer in den gastrointestinaltrakt
|
US5391712A
(en)
*
|
1991-08-30 |
1995-02-21 |
Beckman Instruments, Inc. |
Non-hemolytic streptolysin O variants
|
US5378620A
(en)
*
|
1991-08-30 |
1995-01-03 |
Beckman Instruments, Inc. |
Streptolysin O derivatives
|
US5268376A
(en)
|
1991-09-04 |
1993-12-07 |
Minnesota Mining And Manufacturing Company |
1-substituted 1H-imidazo[4,5-c]quinolin-4-amines
|
FR2681786A1
(fr)
|
1991-09-27 |
1993-04-02 |
Centre Nat Rech Scient |
Vecteurs recombinants d'origine virale, leur procede d'obtention et leur utilisation pour l'expression de polypeptides dans des cellules musculaires.
|
NZ244306A
(en)
|
1991-09-30 |
1995-07-26 |
Boehringer Ingelheim Int |
Composition for introducing nucleic acid complexes into eucaryotic cells, complex containing nucleic acid and endosomolytic agent, peptide with endosomolytic domain and nucleic acid binding domain and preparation
|
IL103059A0
(en)
|
1991-09-30 |
1993-02-21 |
Boehringer Ingelheim Int |
Conjugates for introducing nucleic acid into higher eucaryotic cells
|
US5266575A
(en)
|
1991-11-06 |
1993-11-30 |
Minnesota Mining And Manufacturing Company |
2-ethyl 1H-imidazo[4,5-ciquinolin-4-amines
|
US5252479A
(en)
|
1991-11-08 |
1993-10-12 |
Research Corporation Technologies, Inc. |
Safe vector for gene therapy
|
WO1993010218A1
(en)
|
1991-11-14 |
1993-05-27 |
The United States Government As Represented By The Secretary Of The Department Of Health And Human Services |
Vectors including foreign genes and negative selective markers
|
GB9125623D0
(en)
|
1991-12-02 |
1992-01-29 |
Dynal As |
Cell modification
|
JPH07503372A
(ja)
|
1992-01-23 |
1995-04-13 |
バイカル・インコーポレイテッド |
生体外遺伝子導入
|
IT1262896B
(it)
|
1992-03-06 |
1996-07-22 |
|
Composti coniugati formati da proteine heat shock (hsp) e oligo-poli- saccaridi, loro uso per la produzione di vaccini.
|
FR2688514A1
(fr)
|
1992-03-16 |
1993-09-17 |
Centre Nat Rech Scient |
Adenovirus recombinants defectifs exprimant des cytokines et medicaments antitumoraux les contenant.
|
MA22842A1
(fr)
|
1992-03-27 |
1993-10-01 |
Smithkline Beecham Biolog |
Procede de preparation de compositions de vaccin.
|
IL105325A
(en)
|
1992-04-16 |
1996-11-14 |
Minnesota Mining & Mfg |
Immunogen/vaccine adjuvant composition
|
JPH07507689A
(ja)
|
1992-06-08 |
1995-08-31 |
ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア |
特定組織のターゲティング方法及び組成物
|
EP0644946A4
(en)
|
1992-06-10 |
1997-03-12 |
Us Health |
VECTOR PARTICLES RESISTANT TO HUMAN SERUM INACTIVATION.
|
EP0671948B1
(en)
|
1992-06-25 |
1997-08-13 |
SMITHKLINE BEECHAM BIOLOGICALS s.a. |
Vaccine composition containing adjuvants
|
IL102687A
(en)
|
1992-07-30 |
1997-06-10 |
Yeda Res & Dev |
Conjugates of poorly immunogenic antigens and synthetic pepide carriers and vaccines comprising them
|
GB2269175A
(en)
|
1992-07-31 |
1994-02-02 |
Imperial College |
Retroviral vectors
|
ES2312164T3
(es)
|
1992-09-25 |
2009-02-16 |
Aventis Pharma S.A. |
Vectores de adenovirus para la transferencia de genes extraños en celulas del sistema nervioso central, particularmente en el cerebro.
|
DE69331526T2
(de)
|
1992-11-18 |
2002-10-24 |
Arch Development Corp., Chicago |
Adenovirus gelenkter gen-transfer zum herz- und glatten vaskularen muskel
|
DE4240056A1
(de)
*
|
1992-11-28 |
1994-06-01 |
Boehringer Mannheim Gmbh |
Streptolysin O Peptidantigene und Verfahren zur Bestimmung von Streptolysin-Antikörper
|
EP0911413A3
(en)
|
1992-12-03 |
2000-11-15 |
Genzyme Corporation |
Minimal adenovirus-based gene therapy vector
|
US5478745A
(en)
|
1992-12-04 |
1995-12-26 |
University Of Pittsburgh |
Recombinant viral vector system
|
US5395937A
(en)
|
1993-01-29 |
1995-03-07 |
Minnesota Mining And Manufacturing Company |
Process for preparing quinoline amines
|
US5348358A
(en)
|
1993-02-22 |
1994-09-20 |
Selick David A |
Contact lens insertion tool
|
ES2109685T5
(es)
|
1993-03-23 |
2005-09-01 |
Smithkline Beecham Biologicals S.A. |
Composiciones para vacunas que contienen monofosforil-lipido a 3-o-desacilado.
|
DE4311651A1
(de)
|
1993-04-08 |
1994-10-13 |
Boehringer Ingelheim Int |
Virus für den Transport von Fremd-DNA in höhere eukaryotische Zellen
|
ES2188612T3
(es)
|
1993-04-22 |
2003-07-01 |
Skyepharma Inc |
Liposomas multivesiculares de ciclodextrina para encapsular compuestos farmacologicos y metodos para su uso.
|
CA2162271A1
(en)
|
1993-05-26 |
1994-12-08 |
Robert Kotin |
Fusion proteins containing adeno-associated virus rep protein and bacterial protein
|
FR2705686B1
(fr)
|
1993-05-28 |
1995-08-18 |
Transgene Sa |
Nouveaux adénovirus défectifs et lignées de complémentation correspondantes.
|
EP0660874B1
(en)
*
|
1993-06-23 |
2003-09-03 |
Beckman Coulter, Inc. |
Recombinant dnase b derived from streptococcus pyogenes
|
DE69434486T2
(de)
|
1993-06-24 |
2006-07-06 |
Advec Inc. |
Adenovirus vektoren für gentherapie
|
PL179877B1
(pl)
|
1993-07-13 |
2000-11-30 |
Rhone Poulenc Rorer Sa |
Zdefektowany replikacyjnie adenowirus, linia komórkowa do infekowania zdefektowanym adenowirusem oraz srodek farmaceutyczny PL PL PL PL PL PL PL PL PL PL
|
WO1995002597A1
(en)
|
1993-07-15 |
1995-01-26 |
Minnesota Mining And Manufacturing Company |
IMIDAZO[4,5-c]PYRIDIN-4-AMINES
|
US5352784A
(en)
|
1993-07-15 |
1994-10-04 |
Minnesota Mining And Manufacturing Company |
Fused cycloalkylimidazopyridines
|
CA2167706A1
(en)
|
1993-07-27 |
1995-02-09 |
Nigel Fraser |
Modified dna virus vectors and uses therefor
|
US5631236A
(en)
|
1993-08-26 |
1997-05-20 |
Baylor College Of Medicine |
Gene therapy for solid tumors, using a DNA sequence encoding HSV-Tk or VZV-Tk
|
US5362865A
(en)
|
1993-09-02 |
1994-11-08 |
Monsanto Company |
Enhanced expression in plants using non-translated leader sequences
|
EP0716148B1
(en)
|
1993-09-15 |
2004-01-02 |
Chiron Corporation |
Recombinant alphavirus vectors
|
FR2710536B1
(fr)
|
1993-09-29 |
1995-12-22 |
Transgene Sa |
Usage anti-cancéreux d'un vecteur viral comportant un gène modulateur de la réponse immunitaire et/ou inflammatoire.
|
WO1995009654A1
(en)
|
1993-10-01 |
1995-04-13 |
The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services |
Gene therapy of the nervous system
|
WO1995011984A2
(en)
|
1993-10-25 |
1995-05-04 |
Canji, Inc. |
Recombinant adenoviral vector and methods of use
|
WO1995011700A1
(en)
|
1993-10-29 |
1995-05-04 |
Pharmos Corp. |
Submicron emulsions as vaccine adjuvants
|
BR9408072A
(pt)
|
1993-11-16 |
1997-08-12 |
Depotech Corp |
Vesículas com liberação controlada de ativos
|
US5693506A
(en)
|
1993-11-16 |
1997-12-02 |
The Regents Of The University Of California |
Process for protein production in plants
|
FR2712603B1
(fr)
|
1993-11-18 |
1996-02-09 |
Centre Nat Rech Scient |
Virus recombinants, préparation et utilisation en thérapie génique.
|
US5585098A
(en)
*
|
1993-11-23 |
1996-12-17 |
Ovimmune, Inc. |
Oral administration of chicken yolk immunoglobulins to lower somatic cell count in the milk of lactating ruminants
|
GB9326174D0
(en)
|
1993-12-22 |
1994-02-23 |
Biocine Sclavo |
Mucosal adjuvant
|
GB9326253D0
(en)
|
1993-12-23 |
1994-02-23 |
Smithkline Beecham Biolog |
Vaccines
|
JPH07241786A
(ja)
|
1994-03-08 |
1995-09-19 |
Fanuc Ltd |
産業用ロボットの制御装置
|
US6780406B1
(en)
|
1994-03-21 |
2004-08-24 |
The Regents Of The University Of Michigan |
Inhibition of vascular smooth muscle cell proliferation administering a thymidine kinase gene
|
US7252989B1
(en)
|
1994-04-04 |
2007-08-07 |
Board Of Regents, The University Of Texas System |
Adenovirus supervector system
|
JPH10507061A
(ja)
|
1994-04-28 |
1998-07-14 |
ザ ユニバーシティ オブ ミシガン |
アデノウイルス中にパッケージされたプラスミドdnaを用いる遺伝子送達ベクターおよびパッケージング細胞株
|
AU2585395A
(en)
|
1994-05-09 |
1995-11-29 |
Chiron Corporation |
Retroviral vectors having a reduced recombination rate
|
EP1548118A2
(en)
|
1994-06-10 |
2005-06-29 |
Genvec, Inc. |
Complementary adenoviral vector systems and cell lines
|
US6429199B1
(en)
|
1994-07-15 |
2002-08-06 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules for activating dendritic cells
|
US6207646B1
(en)
|
1994-07-15 |
2001-03-27 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules
|
US6239116B1
(en)
|
1994-07-15 |
2001-05-29 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules
|
FR2723588B1
(fr)
|
1994-08-12 |
1996-09-20 |
Rhone Poulenc Rorer Sa |
Adenovirus comprenant un gene codant pour la glutathion peroxydase
|
US5496284A
(en)
|
1994-09-27 |
1996-03-05 |
Waldenburg; Ottfried |
Dual-chamber syringe & method
|
AUPM873294A0
(en)
|
1994-10-12 |
1994-11-03 |
Csl Limited |
Saponin preparations and use thereof in iscoms
|
AUPM885194A0
(en)
*
|
1994-10-14 |
1994-11-10 |
Council Of The Queensland Institute Of Medical Research, The |
Synthetic peptides and vaccines comprising same
|
US5482936A
(en)
|
1995-01-12 |
1996-01-09 |
Minnesota Mining And Manufacturing Company |
Imidazo[4,5-C]quinoline amines
|
GB9503863D0
(en)
|
1995-02-25 |
1995-04-19 |
Smithkline Beecham Biolog |
Vaccine compositions
|
UA56132C2
(uk)
|
1995-04-25 |
2003-05-15 |
Смітклайн Бічем Байолоджікалс С.А. |
Композиція вакцини (варіанти), спосіб стабілізації qs21 відносно гідролізу (варіанти), спосіб приготування композиції вакцини
|
AU5741996A
(en)
|
1995-05-22 |
1996-12-11 |
Chiron Corporation |
Position-specific integration of vector constructs into eukaryotic genomes mediated by a chimeric integrase protein
|
US6284884B1
(en)
*
|
1995-06-07 |
2001-09-04 |
North American Vaccine, Inc. |
Antigenic group B streptococcus type II and type III polysaccharide fragments having a 2,5-anhydro-D-mannose terminal structure and conjugate vaccine thereof
|
US6936259B2
(en)
*
|
1995-06-08 |
2005-08-30 |
University Of Saskatchewan |
CAMP factor of Streptococcus uberis
|
GB9513261D0
(en)
|
1995-06-29 |
1995-09-06 |
Smithkline Beecham Biolog |
Vaccines
|
US5846547A
(en)
*
|
1996-01-22 |
1998-12-08 |
Regents Of The University Of Minnesota |
Streptococcal C5a peptidase vaccine
|
WO1998001174A1
(fr)
|
1996-07-05 |
1998-01-15 |
Debiotech S.A. |
Seringue a chambre double permettant le melange de deux produits avant leur injection
|
WO1998006437A2
(en)
|
1996-08-13 |
1998-02-19 |
Chiron Corporation |
Compositions and methods for polynucleotide delivery
|
US5980898A
(en)
|
1996-11-14 |
1999-11-09 |
The United States Of America As Represented By The U.S. Army Medical Research & Material Command |
Adjuvant for transcutaneous immunization
|
US7033765B1
(en)
*
|
1997-02-20 |
2006-04-25 |
Toronto Research Chemicals, Inc. |
Site-specific drug delivery
|
PT1005368E
(pt)
|
1997-03-10 |
2009-11-19 |
Coley Pharm Gmbh |
Utilização de ácidos nucleicos contendo dinucleótidos cpg não metilados em combinação com alúmen como adjuvante
|
US6426074B1
(en)
*
|
1997-03-19 |
2002-07-30 |
The Brigham And Women's Hospital Inc. |
Group B Streptococcus vaccine
|
US6818222B1
(en)
|
1997-03-21 |
2004-11-16 |
Chiron Corporation |
Detoxified mutants of bacterial ADP-ribosylating toxins as parenteral adjuvants
|
US6299881B1
(en)
|
1997-03-24 |
2001-10-09 |
Henry M. Jackson Foundation For The Advancement Of Military Medicine |
Uronium salts for activating hydroxyls, carboxyls, and polysaccharides, and conjugate vaccines, immunogens, and other useful immunological reagents produced using uronium salts
|
JP2002516571A
(ja)
*
|
1997-05-06 |
2002-06-04 |
ヒューマン ジノーム サイエンシーズ,インコーポレイテッド |
Enterococcus faecalisポリヌクレオチドおよびポリペプチド
|
US6080725A
(en)
|
1997-05-20 |
2000-06-27 |
Galenica Pharmaceuticals, Inc. |
Immunostimulating and vaccine compositions employing saponin analog adjuvants and uses thereof
|
US6635623B1
(en)
*
|
1997-06-13 |
2003-10-21 |
Baylor College Of Medicine |
Lipoproteins as nucleic acid vectors
|
GB9712347D0
(en)
|
1997-06-14 |
1997-08-13 |
Smithkline Beecham Biolog |
Vaccine
|
GB9713156D0
(en)
|
1997-06-20 |
1997-08-27 |
Microbiological Res Authority |
Vaccines
|
AU1145699A
(en)
|
1997-09-05 |
1999-03-22 |
Smithkline Beecham Biologicals (Sa) |
Oil in water emulsions containing saponins
|
US6406883B1
(en)
*
|
1997-09-26 |
2002-06-18 |
Luetticken Rudolf |
Lmb gene of Streptococcus agalactiae
|
AU9785598A
(en)
|
1997-10-03 |
1999-04-27 |
Texas Pharmaceuticals, Inc. |
Improved dual chamber syringe apparatus
|
US5971953A
(en)
|
1998-01-09 |
1999-10-26 |
Bachynsky; Nicholas |
Dual chamber syringe apparatus
|
BR9813071A
(pt)
*
|
1997-10-17 |
2000-08-15 |
Nestle Sa |
Espécie de bactéria láctica
|
US5967763A
(en)
*
|
1997-10-21 |
1999-10-19 |
Horng; Ching-Shen |
Positioning devices for a sensor element of a miniature fan
|
GB9725084D0
(en)
|
1997-11-28 |
1998-01-28 |
Medeva Europ Ltd |
Vaccine compositions
|
NZ504894A
(en)
|
1997-12-02 |
2002-12-20 |
Powderject Vaccines Inc |
Crystalline vaccine and adjuvant compositions jointly and separately administered to animals using a transdermal or transmucosally delivery technique
|
CA2315880A1
(en)
*
|
1997-12-31 |
1999-07-15 |
Stressgen Biotechnologies Corporation |
Streptococcal heat shock proteins of the hsp60 family
|
US7041814B1
(en)
*
|
1998-02-18 |
2006-05-09 |
Genome Therapeutics Corporation |
Nucleic acid and amino acid sequences relating to Enterobacter cloacae for diagnostics and therapeutics
|
CA2325939A1
(en)
|
1998-04-09 |
1999-10-21 |
Martin Friede |
Vaccine
|
GB9808327D0
(en)
*
|
1998-04-20 |
1998-06-17 |
Chiron Spa |
Antidiotypic compounds
|
CN101219217A
(zh)
|
1998-05-07 |
2008-07-16 |
科里克萨有限公司 |
佐剂组合物及其使用方法
|
US6562798B1
(en)
|
1998-06-05 |
2003-05-13 |
Dynavax Technologies Corp. |
Immunostimulatory oligonucleotides with modified bases and methods of use thereof
|
US6660520B2
(en)
*
|
1998-06-05 |
2003-12-09 |
Smithkline Beecham Corporation |
Nrde
|
US6936252B2
(en)
*
|
1998-07-27 |
2005-08-30 |
Microbial Technics Limited |
Streptococcus pneumoniae proteins and nucleic acid molecules
|
US7098182B2
(en)
*
|
1998-07-27 |
2006-08-29 |
Microbial Technics Limited |
Nucleic acids and proteins from group B streptococcus
|
US6110929A
(en)
|
1998-07-28 |
2000-08-29 |
3M Innovative Properties Company |
Oxazolo, thiazolo and selenazolo [4,5-c]-quinolin-4-amines and analogs thereof
|
GB9817052D0
(en)
|
1998-08-05 |
1998-09-30 |
Smithkline Beecham Biolog |
Vaccine
|
AT408615B
(de)
|
1998-09-15 |
2002-01-25 |
Immuno Ag |
Neue influenzavirus-impfstoffzusammensetzung
|
US7128918B1
(en)
*
|
1998-12-23 |
2006-10-31 |
Id Biomedical Corporation |
Streptococcus antigens
|
US20030130212A1
(en)
|
1999-01-14 |
2003-07-10 |
Rossignol Daniel P. |
Administration of an anti-endotoxin drug by intravenous infusion
|
US6551600B2
(en)
|
1999-02-01 |
2003-04-22 |
Eisai Co., Ltd. |
Immunological adjuvant compounds compositions and methods of use thereof
|
WO2000046147A2
(en)
|
1999-02-03 |
2000-08-10 |
Biosante Pharmaceuticals, Inc. |
Therapeutic calcium phosphate particles and methods of manufacture and use
|
CZ303653B6
(cs)
*
|
1999-03-19 |
2013-01-30 |
Smithkline Beecham Biologicals S. A. |
Imunogenní prostredek
|
ATE549032T1
(de)
|
1999-03-26 |
2012-03-15 |
Vical Inc |
Adjuvanzverbindungen zur verbesserung von immunreaktionen auf polynukleotid-basierten impfstoffen
|
US7101692B2
(en)
*
|
1999-04-15 |
2006-09-05 |
The Regents Of The University Of California |
Identification of sortase gene
|
US6331539B1
(en)
|
1999-06-10 |
2001-12-18 |
3M Innovative Properties Company |
Sulfonamide and sulfamide substituted imidazoquinolines
|
US6833356B1
(en)
*
|
1999-08-25 |
2004-12-21 |
Medimmune, Inc. |
Pneumococcal protein homologs and fragments for vaccines
|
AU765824B2
(en)
|
1999-09-24 |
2003-10-02 |
Smithkline Beecham Biologicals (Sa) |
Vaccines
|
PL355232A1
(en)
|
1999-09-24 |
2004-04-05 |
Smithkline Beecham Biologicals S.A. |
Adjuvant comprising a polyxyethylene alkyl ether or ester and at least one nonionic surfactant
|
TR200503031T2
(tr)
|
1999-09-25 |
2005-09-21 |
University Of Iowa Research Foundation |
İmmünostimülatör nükleik asitler
|
CA2384713A1
(en)
*
|
1999-09-29 |
2001-04-05 |
Human Genome Sciences, Inc. |
Colon and colon cancer associated polynucleotides and polypeptides
|
GB9923176D0
(en)
|
1999-09-30 |
1999-12-01 |
Smithkline Beecham Biolog |
Novel composition
|
AU3108001A
(en)
|
2000-01-20 |
2001-12-24 |
Coley Pharmaceutical Group, Inc. |
Immunostimulatory nucleic acids for inducing a th2 immune response
|
US6777547B1
(en)
*
|
2000-01-31 |
2004-08-17 |
Andreas Podbielski |
Collagen-binding proteins from streptococcus pyogenes
|
JP4852211B2
(ja)
*
|
2000-03-21 |
2012-01-11 |
メルク アンド カンパニー インコーポレイテッド |
原核生物における必須遺伝子の同定
|
GB0007432D0
(en)
|
2000-03-27 |
2000-05-17 |
Microbiological Res Authority |
Proteins for use as carriers in conjugate vaccines
|
AUPQ801700A0
(en)
*
|
2000-06-07 |
2000-06-29 |
Peplin Research Pty Ltd |
Enzyme and viral activation
|
WO2002004495A2
(en)
*
|
2000-07-06 |
2002-01-17 |
Shire Biochem Inc. |
Streptococcus pyogenes antigen
|
DE60128115T2
(de)
*
|
2000-08-08 |
2008-03-06 |
St. Jude Children's Research Hospital, Memphis |
Gruppe-b streptococcus polypeptide, nukleinsäure, therapeutische zusammensetzungen und impfstoffe davon
|
DE60140456D1
(de)
|
2000-09-01 |
2009-12-24 |
Novartis Vaccines & Diagnostic |
Aza heterocyclische derivate und ihre therapeutische verwendung
|
KR100732206B1
(ko)
|
2000-09-11 |
2007-06-27 |
노바티스 백신즈 앤드 다이아그노스틱스 인코포레이티드 |
티로신 키나제 억제제로서의 퀴놀리논 유도체
|
US7262286B2
(en)
|
2000-09-26 |
2007-08-28 |
Idera Pharmaceuticals, Inc. |
Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changes
|
WO2002057315A2
(en)
*
|
2000-10-10 |
2002-07-25 |
University Of Tennessee Research Corporation |
Streptococcal streptolysin s vaccines
|
US7160547B2
(en)
*
|
2000-10-10 |
2007-01-09 |
University Of Tennessee Research Corporation |
Streptococcal streptolysin S vaccines
|
SG165981A1
(en)
*
|
2000-10-27 |
2010-11-29 |
Chiron Srl |
Nucleic acids and proteins from streptococcus groups a & b
|
US6677347B2
(en)
|
2000-12-08 |
2004-01-13 |
3M Innovative Properties Company |
Sulfonamido ether substituted imidazoquinolines
|
US6664264B2
(en)
|
2000-12-08 |
2003-12-16 |
3M Innovative Properties Company |
Thioether substituted imidazoquinolines
|
US6660735B2
(en)
|
2000-12-08 |
2003-12-09 |
3M Innovative Properties Company |
Urea substituted imidazoquinoline ethers
|
US6664260B2
(en)
|
2000-12-08 |
2003-12-16 |
3M Innovative Properties Company |
Heterocyclic ether substituted imidazoquinolines
|
US6667312B2
(en)
|
2000-12-08 |
2003-12-23 |
3M Innovative Properties Company |
Thioether substituted imidazoquinolines
|
UA75622C2
(en)
|
2000-12-08 |
2006-05-15 |
3M Innovative Properties Co |
Aryl ether substituted imidazoquinolines, pharmaceutical composition based thereon
|
US6677348B2
(en)
|
2000-12-08 |
2004-01-13 |
3M Innovative Properties Company |
Aryl ether substituted imidazoquinolines
|
US6664265B2
(en)
|
2000-12-08 |
2003-12-16 |
3M Innovative Properties Company |
Amido ether substituted imidazoquinolines
|
US6660747B2
(en)
|
2000-12-08 |
2003-12-09 |
3M Innovative Properties Company |
Amido ether substituted imidazoquinolines
|
MXPA03008154A
(es)
|
2001-03-09 |
2004-11-12 |
Id Biomedical Corp Quebec |
Novedoso adyuvante de vacuna de proteosoma-liposacarido.
|
GB0107658D0
(en)
*
|
2001-03-27 |
2001-05-16 |
Chiron Spa |
Streptococcus pneumoniae
|
EP1421098A4
(en)
*
|
2001-04-13 |
2006-03-15 |
Wyeth Corp |
SURFACE PROTEINS OF STREPTOCOCCUS PYOGENES
|
US20070128229A1
(en)
*
|
2002-04-12 |
2007-06-07 |
Wyeth |
Surface proteins of Streptococcus pyogenes
|
ATE557041T1
(de)
*
|
2001-05-18 |
2012-05-15 |
Us Gov Health & Human Serv |
Peptid-vakzinen gegen streptokokken der gruppe a
|
MY134424A
(en)
|
2001-05-30 |
2007-12-31 |
Saechsisches Serumwerk |
Stable influenza virus preparations with low or no amount of thiomersal
|
GB0118249D0
(en)
*
|
2001-07-26 |
2001-09-19 |
Chiron Spa |
Histidine vaccines
|
US20060073530A1
(en)
*
|
2001-08-15 |
2006-04-06 |
Olaf Schneewind |
Methods and compositions involving sortase B
|
GB0123580D0
(en)
|
2001-10-01 |
2001-11-21 |
Glaxosmithkline Biolog Sa |
Vaccine
|
WO2003035836A2
(en)
|
2001-10-24 |
2003-05-01 |
Hybridon Inc. |
Modulation of immunostimulatory properties of oligonucleotide-based compounds by optimal presentation of 5' ends
|
US20040029129A1
(en)
*
|
2001-10-25 |
2004-02-12 |
Liangsu Wang |
Identification of essential genes in microorganisms
|
US7321033B2
(en)
|
2001-11-27 |
2008-01-22 |
Anadys Pharmaceuticals, Inc. |
3-B-D-ribofuranosylthiazolo [4,5-d] pyrimidine nucleosides and uses thereof
|
CN1300165C
(zh)
|
2001-11-27 |
2007-02-14 |
安那迪斯药品股份有限公司 |
3-β-呋喃核糖基噻唑并[4,5-d]嘧啶核苷及其应用
|
US6677349B1
(en)
|
2001-12-21 |
2004-01-13 |
3M Innovative Properties Company |
Sulfonamide and sulfamide substituted imidazoquinolines
|
GB2385274B
(en)
*
|
2002-02-13 |
2004-04-14 |
Ming-Jeng Shue |
Vaginal suppository delivery device
|
PL402389A1
(pl)
|
2002-03-29 |
2013-04-02 |
Novartis Ag |
Sposób hamowania aktywnosci kinazy Raf u ludzi lub zwierzat
|
US20050181388A1
(en)
*
|
2002-04-02 |
2005-08-18 |
Affinium Pharmaceuticals, Inc. |
Novel purified polypeptides from bacteria
|
AU2003213949A1
(en)
*
|
2002-04-08 |
2003-10-27 |
Affinium Pharmaceuticals, Inc. |
Purified polypeptides involved in membrane biogenesis
|
GB0210128D0
(en)
*
|
2002-05-02 |
2002-06-12 |
Chiron Spa |
Nucleic acids and proteins from streptococcus groups A & B
|
WO2003101949A2
(en)
|
2002-05-29 |
2003-12-11 |
3M Innovative Properties Company |
Process for imidazo[4,5-c]pyridin-4-amines
|
SE0202110D0
(sv)
|
2002-07-05 |
2002-07-05 |
Isconova Ab |
Iscom preparation and use thereof
|
US7250443B2
(en)
|
2002-08-23 |
2007-07-31 |
Chiron Corporation |
Pyrrole based inhibitors of glycogen synthase kinase 3
|
WO2004018646A2
(en)
*
|
2002-08-26 |
2004-03-04 |
Chiron Corporation |
Conserved and specific streptococcal genomes
|
AU2003299535A1
(en)
*
|
2002-09-13 |
2004-06-07 |
Chiron Corporation |
Group b streptococcus vaccine
|
TW566366U
(en)
*
|
2002-09-27 |
2003-12-11 |
Wus Tech Co Ltd |
Labor-saving portable battery equipment for power-driven walking assisted scooter
|
WO2004035618A2
(en)
*
|
2002-10-15 |
2004-04-29 |
Intercell Ag |
Nucleic acids coding for adhesion factor of group b streptococcus, adhesion factors of group b streptococcus and further uses thereof
|
WO2004060308A2
(en)
|
2002-12-27 |
2004-07-22 |
Chiron Corporation |
Thiosemicarbazones as anti-virals and immunopotentiators
|
WO2004064759A2
(en)
|
2003-01-21 |
2004-08-05 |
Chiron Corporation |
Use of tryptanthrin compounds for immune potentiation
|
GB0301554D0
(en)
|
2003-01-23 |
2003-02-26 |
Molecularnature Ltd |
Immunostimulatory compositions
|
EP2287312A1
(en)
*
|
2003-03-04 |
2011-02-23 |
Intercell AG |
Streptococcus pyogenes antigens
|
EP2258365B1
(en)
|
2003-03-28 |
2013-05-29 |
Novartis Vaccines and Diagnostics, Inc. |
Use of organic compounds for immunopotentiation
|
CN101864431A
(zh)
|
2003-05-07 |
2010-10-20 |
英特塞尔股份公司 |
无乳链球菌抗原ⅰ和ⅱ
|
SE0301998D0
(sv)
|
2003-07-07 |
2003-07-07 |
Isconova Ab |
Quil A fraction with low toxicity and use thereof
|
JP4875490B2
(ja)
*
|
2003-07-31 |
2012-02-15 |
ノバルティス バクシンズ アンド ダイアグノスティックス,インコーポレーテッド |
StreptococcusPyogenesについての免疫原組成物
|
AU2003904237A0
(en)
*
|
2003-08-08 |
2003-08-21 |
Garvan Institute Of Medical Research |
Novel translocation assay
|
US8945589B2
(en)
*
|
2003-09-15 |
2015-02-03 |
Novartis Vaccines And Diagnostics, Srl |
Immunogenic compositions for Streptococcus agalactiae
|
CA2537742C
(en)
|
2003-09-15 |
2014-07-22 |
Chiron Corporation |
Immunogenic compositions for streptococcus agalactiae
|
JP2007520718A
(ja)
*
|
2004-02-06 |
2007-07-26 |
カウンシル オブ サイエンティフィック アンド インダストリアル リサーチ |
治療可能性のあるアドヘシンおよびアドヘシン様タンパク質を同定するためのコンピュータを利用した方法
|
KR101153898B1
(ko)
|
2004-03-23 |
2012-06-18 |
니프로 가부시키가이샤 |
프리필드 시린지
|
US20060041961A1
(en)
*
|
2004-03-25 |
2006-02-23 |
Abad Mark S |
Genes and uses for pant improvement
|
SI1742659T1
(sl)
|
2004-04-05 |
2013-07-31 |
Zoetis P Llc |
Mikrofluidizirane emulzije olja v vodi in sestavki cepiv
|
US20060165716A1
(en)
*
|
2004-07-29 |
2006-07-27 |
Telford John L |
Immunogenic compositions for gram positive bacteria such as streptococcus agalactiae
|
CA2582137A1
(en)
*
|
2004-10-05 |
2007-02-15 |
Wyeth |
Probe arrays for detecting multiple strains of different species
|